Friday, October 6, 2017
News Recap:
Liver Cancer
Two studies on liver cancer in the news last week highlighted the global prevalence and causes of this terrible disease. The first showed a direct correlation between excess weight and cancer occurrence (including liver cancer) – Cancers linked to excess weight make up 40% of all US diagnoses, study finds, while the second focussed on the global incidence of primary liver cancer. Hepatitis B virus wa...
Primary liver cancer incidence increased by 75% between 1990 and 2015, and the disease remains one of the leading causes of cancer death in the world, according to a report from the Global Burden of Diseases Study 2015.
Further, hepatitis B virus was the leading cause of new cases of liver cancer in 2015, the research showed.
The highest rates of liver cancer incidence, disability-adjusted life-years and mortality occurred in East Asia. Japan had 75% o
Friday, August 25, 2017
News Recap:
Public health issues Hep B risk warning: Tools used in procedures such as callus scraping and cutting toenails could become contaminated with the virus and remain contaminated because of the sterilization practices followed. Public health authorities in Owen Sound have identified a local foot care clinic as a potential source of hepatitis B and are warning patients – other than orthotics patients – to consult a doc...
American Indian tribal citizens and other native peoples around the world are up to 10 times more likely to be infected with viral hepatitis than others in their countries, according to a global analysis of data on the liver-attacking diseases.
"Indigenous peoples worldwide are bearing a disproportionately high burden of hepatitis B, hepatitis C, or both,” said Raquel Peck, chief Executive of the London-based World Hepatitis Alliance.
Poverty, injectio
An estimated 325 million people are living with hepatitis B or C and few are aware of their condition, with death tolls from the viruses rising, the UN said Friday.
The World Health Organization's latest hepatitis report identifies the condition as a grave public health threat that needs an "urgent response."
Hepatitis killed 1.34 million people in 2015, a toll roughly in-line with HIV and tuberculosis.
But in contrast to HIV and TB, hepatitis death
Survival rates are rising but more than 1,000 people die every year in Ontario from liver cancer.
Liver cancer is to blame for more than a thousand deaths every year in Ontario — and most of these occur in the Greater Toronto Area. In fact, the epidemic level of liver cancer in this city often goes unrecognized, as it’s diluted by provincial and national statistics.
So what is it about Toronto that makes it such a hot spot for this type of cancer?
M
It is possible to end the transmission of hepatitis B and C and prevent further sickness and deaths from the diseases, but time, considerable resources, and attention to various barriers will be required, says a new report from the National Academies of Sciences, Engineering, and Medicine. However, controlling the diseases by reducing the number of new and overall cases in the U.S. is more feasible in the short term. This is the first report of a two-phase
AIDS expert Dr. Julio Montaner and B.C.’s Ministry of Health are planning to take on another infectious disease with potentially deadly consequences: hepatitis C.Speaking at a news conference Tuesday on Vancouver’s Downtown Eastside — where an estimated 80 per cent of area drug users have hep C — Health Minister Terry Lake said publicly funded treatment is now restricted to people who already have considerable liver damage, but that could change.“What Dr.
HepCBC is seeking individual patient input for our submission to the federal government for an INTERFERON-FREE, ONE PILL/DAY drug combo, shown to be effective for genotypes 1, 3, 4, and 6, Merck Pharmaceutical's elbasvir + grazoprevir (± ribavirin). The treatment's success (96% - 100% SVR12) has been confirmed in trials including people considered 'hard to treat' including those who had failed previous treatment (including simeprevir, boceprevir, and telap
HepCBC is seeking individual patient input for our submission to the federal government for the first INTERFERON-FREE drug combo for GENOTYPE 4, AbbVie's "2D-GT4".ADD YOUR VOICE! We will be accepting input from anyone affected by hepatitis C (ALL GENOTYPES, not only Genotype 4) between Friday, Sept. 11 and midnight on Thursday, Sept. 25, 2015 through this confidential online form: PATIENT INPUT FORM for AbbVie 2D-GT4 Free WEBINAR about AbbVie 2D-GT4 availa
